Our mission is to disrupt the field of surgery and positively impact the lives of patients through the development of our platform of biomorphic programmable polymers
A NEW ERA OF RECONSTRUCTIVE POLYMERS
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures:
To reconstruct damaged tissue and restore its natural function.
TISSUE RECONSTRUCTION
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.
POTENTIAL
Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas.
Kirsty Doolan 12 February 2025 We examine what's new in tropical and ingestible beauty products…
10 February 2025 IFF announces the launch of its new artificial intelligence (AI)-powered search tool:…
Renata Martins 6 February 2025 The global cosmetics market is evolving rapidly with an influx…